Japanese Trade Distributors Stock News

Nidec (TSE:6594) is back in focus after its board resolved to skip the year end dividend for the fiscal year ending March 2026, following a Third Party Committee report on inappropriate accounting treatment. See our latest analysis for Nidec. The latest decision to skip the year end dividend comes on top of a 14.96% 3 month share price return and a 10.56% year to date share price return. At the same time, the 1 year total shareholder return of 13.24% and 5 year total shareholder return of...

Tomoe Engineering (TSE:6309) opened its 2026 financial year with Q1 revenue of ¥15.3 billion and basic EPS of ¥37.61, alongside net income of ¥1,110 million, setting a clear marker for how the new fiscal period is starting. The company has seen revenue move from ¥15.1 billion and EPS of ¥41.35 in Q1 2025 to ¥15.3 billion and EPS of ¥37.61 in Q1 2026, with trailing twelve month EPS at ¥124.81 and net income at ¥3,723 million, which gives you a fuller read on earnings power beyond a single...

Kakiyasu Honten (TSE:2294) has put up a mixed Q3 2026 scorecard, with revenue at ¥10.9b and basic EPS of ¥66.58, alongside trailing 12 month EPS of ¥65.03 and net income of ¥623m that sit against a compressed net margin and a large one off loss over the year. The company has seen quarterly revenue move between ¥8.2b and ¥10.9b and basic EPS swing from a loss of ¥19.93 per share in Q4 2025 to a recent range between ¥3.03 and ¥74.64. This leaves investors weighing the current payout and margin...

Timee (TSE:215A) kicked off Q1 2026 with total revenue of ¥10.9b and basic EPS of ¥14.29, while trailing twelve month revenue came in at ¥36.5b and EPS at ¥54.39, against a backdrop of 50.7% earnings growth over the past year. Over recent quarters, the company has seen revenue move from ¥7.9b in Q4 2024 to ¥8.6b in Q1 2025, then ¥9.5b in Q4 2025 and now ¥10.9b in Q1 2026, with quarterly EPS ranging between ¥12.59 and ¥14.85 over that span. With net profit margin improving to 14.9% from 12.5%...

In March 2026, Daiichi Sankyo and AstraZeneca announced that the U.S. FDA accepted and granted Priority Review to their supplemental Biologics License Application for ENHERTU, targeting adults with HER2 positive breast cancer who have residual invasive disease after neoadjuvant HER2 targeted treatment. The application rests on DESTINY-Breast05 phase 3 data showing ENHERTU cut the risk of invasive disease recurrence or death versus T-DM1, with three-year invasive disease-free survival of...

Mitsubishi Electric (TSE:6503) agreed a partnership with Elephantech to promote eco-friendly inkjet manufacturing of printed circuit boards. The deal includes investment in Elephantech and plans to apply its nano-ink inkjet PCB technology within Mitsubishi Electric's factory automation offerings and mass production lines. The collaboration is aimed at supporting more resource efficient and environmentally focused electronics manufacturing processes. Mitsubishi Electric, a diversified...

PayPay, a SoftBank Group subsidiary, completed the largest US IPO by a Japanese company in a decade, listing on Nasdaq. The shares opened strongly on debut, and SoftBank Group kept substantial voting control after the offering. The deal is the first major US listing for SoftBank since Arm and focuses attention on its fintech and AI platform ambitions. For investors watching TSE:9984, the PayPay IPO arrives at a time when SoftBank Group’s share price sits at ¥3,748.0, with a 1 year return of...

If you are wondering whether Nissan Motor's current share price reflects its true worth, you are not alone, many investors are asking the same question as they reassess the stock. The shares recently closed at ¥381.4, with a 2.1% gain over the last 7 days contrasting with a 6.8% decline over 30 days and a 10.2% decline over 1 year, which can change how investors think about both upside and risk. Recent headlines around Nissan often focus on its position in the global auto sector and how it...

GreenEnergy (TSE:1436) has released its Q3 2026 numbers, reporting revenue of ¥3,977 million and Basic EPS of ¥33.23, while trailing twelve month EPS came in at ¥116.11 on revenue of ¥15.1b. This sets a clear earnings season marker for investors. The company’s revenue has moved from ¥9,899 million in the trailing twelve months to Q2 2025 to ¥15.1b in the latest twelve month period, with EPS over the same span shifting from ¥73.52 to ¥116.11. The latest quarter therefore fits into a year in...

Toyota Tsusho Corporation recently held a board meeting on March 3, 2026, approving an absorption-type company split that transfers part of its Sustainable Materials business to Toyotsu Chemiplas Corporation, following an earlier January 14, 2026 meeting to consider the purchase price in a repurchase tender offer. This reshaping of the Sustainable Materials portfolio highlights how Toyota Tsusho is actively reconfiguring its operations to refine focus within its broader chemicals and...

Why GMO Internet (TSE:4784) is in focus after a free float compliance setback GMO Internet (TSE:4784) has come under closer investor watch after the Tokyo Stock Exchange flagged the company as non compliant with Prime Market free float rules, prompting a multi year plan to lift its tradable share ratio. See our latest analysis for GMO internet. At a share price of ¥734.0, GMO Internet has seen a 1 day share price return decline of 1.87% and a 30 day share price return decline of 8.14%. Its 90...

If you are wondering whether Advantest is priced for perfection or still offers value, you are not alone. This article focuses on what the current share price might be implying. The stock has been volatile recently, with a 4% decline over the last 7 days and an 11.4% decline over the last 30 days, set against a 15.8% gain year to date and a very large 1 year return of 214.6% and around 7x over 3 years. Those moves have kept Advantest on many investors' watchlists, as they reassess what such...

Taisei Corporation announced at its February 26, 2026 board meeting that Member of the Board Junichi Kasahara will become Representative Director on April 1, 2026, alongside a broad reshuffle of executive roles and the retirement of several Executive Vice Presidents into counsellor positions. The transition keeps outgoing Representative Director Masahiko Okada on the board while elevating long-serving internal talent to key operational posts, signaling an internal rebalancing of leadership...

Yamaha (TSE:7951) has drawn fresh attention after its board approved a wide refresh of senior leadership, with multiple executive appointments and retirements scheduled to take effect on April 1, 2026. See our latest analysis for Yamaha. The leadership overhaul comes after a soft patch in the share price, with a 30 day share price return of a 9.24% decline and a 1 year total shareholder return of a 2.23% decline, suggesting sentiment has cooled despite a modest 1.05% year to date share price...

TRIAL Holdings (TSE:141A) is back in focus after reporting steady early 2026 sales. The performance was supported by higher average customer spending, new store openings, format conversions, and seasonal and private-brand promotions across food categories. See our latest analysis for TRIAL Holdings. Against this sales update, TRIAL Holdings’ share price, now at ¥3,855, has seen a 29.58% 1 month share price return and 45.09% 3 month share price return, while the 1 year total shareholder return...

NEOJAPAN (TSE:3921) has put up another solid quarter for FY 2026, with third quarter revenue of ¥2,114.36 million and basic EPS of ¥33.05, while trailing twelve month earnings are reported up 60.1% and the net profit margin has moved to 22.1% from 16% a year earlier. The company has seen revenue move from ¥1,679.00 million in FY 2025 Q2 to ¥2,114.36 million in FY 2026 Q3 and quarterly EPS move from ¥20.53 to ¥33.05 over the same stretch, giving a clear picture of how higher sales and earnings...

ANYCOLOR (TSE:5032) has put fresh numbers on the table for Q3 2026, with Q2 revenue of ¥10.6b and basic EPS of ¥46.44, set against trailing twelve month EPS of ¥240.16 and revenue of ¥51.9b that came alongside 63.3% earnings growth and a net margin of 28.1%. Over the past year, the company has seen revenue move from ¥33.8b to ¥51.9b and trailing EPS lift from ¥142.97 to ¥240.16, giving you a clear view of how the top and bottom lines have tracked together over recent periods. With...

TENPOS HOLDINGS Ltd (TSE:2751) has just posted its Q3 2026 scorecard, with recent quarterly revenue ranging from ¥11.5 billion to ¥13.6 billion and EPS between ¥28.12 and ¥62.40, while trailing twelve month revenue sits at ¥49.6 billion and EPS at ¥152.88. Over the past few quarters, the company has seen revenue move from ¥11.5 billion in Q1 2025 to ¥13.6 billion in Q2 2026, alongside EPS shifting from ¥62.40 in Q1 2025 to ¥38.88 in Q2 2026. This sets up a results picture where slimmer net...

Mitsui High-tec (TSE:6966) has put fresh numbers on the table for FY 2026, with third quarter revenue of ¥54.6b and basic EPS of ¥17.64, while net income excluding extraordinary items came in at ¥3,223m. Over the past few quarters, the company has seen revenue move in a relatively tight band between ¥53.5b and ¥56.7b, with EPS ranging from ¥5.30 in Q1 FY 2026 to ¥17.64 in Q3, against a backdrop of trailing 12 month EPS of ¥56.28 and revenue of ¥219.7b. With net profit margins softer over the...

Recent share performance and what it might signal Hino Motors (TSE:7205) has been under pressure recently, with the share price showing a 2.5% decline over the past day and a 5.7% decline over the past week, extending weakness over the past month. For investors watching shorter term moves, that month performance lines up with a 15.8% decline, while the past 3 months show a 2.1% total return and the past year reflects a 16.3% total return decline. See our latest analysis for Hino Motors. With...

Why the Toro 88 clearance matters for Kaneka The recent FDA 510(k) clearance and first clinical use of Toro Neurovascular’s Toro 88 Superbore Catheter brings Kaneka (TSE:4118) into focus, as Kaneka Medical America leads the product’s commercial launch in the United States. This move strengthens Kaneka’s position in neurovascular devices, adding a new platform alongside its broader materials, medical, and nutrition businesses. It also gives investors a concrete event to reassess how the stock...

pluszero (TSE:5132) has kicked off Q1 2026 earnings season with investors focused on how its recent run of top line and EPS numbers sets the tone for the year. The company reported Q4 2025 revenue of ¥383 million and basic EPS of ¥14.78, alongside trailing twelve month EPS of ¥47.18 on ¥1.55 billion of revenue and a 139.2% earnings increase over the past year. Revenue has moved from ¥1.22 billion with basic EPS of ¥20.02 in the twelve months to Q4 2024 to ¥1.55 billion with basic EPS of...

Recent performance snapshot OSG (TSE:6136) has drawn investor attention after a mixed stretch in its share performance, with negative 1 day, week and month returns, contrasted by gains over the past 3 months, year to date and past year. See our latest analysis for OSG. Recent selling pressure, including a 1 day share price return decline of 2.92% and a 1 month share price return decline of 6.12%, sits against a stronger backdrop, with a 3 month share price return of 9.41% and a 1 year total...

Event driven snapshot of Toray Industries Toray Industries (TSE:3402) has drawn fresh attention after a period where the share price showed mixed short term moves alongside positive longer term total returns, prompting investors to reassess the stock’s recent performance and valuation. See our latest analysis for Toray Industries. At a share price of ¥1,189.5, Toray Industries has experienced short-term share price softness, including a 5.26% 1-month share price return. This contrasts with...